Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Revelation Biosciences Inc’s current trading price is -98.31% away from its 52-week high, while its distance from the 52-week low is 32.92%. The stock’s price range during this period has varied between $0.77 and $60.80. The company, active in the Healthcare sector, saw a trading volume of around 38.13 million for the day, considerably higher average daily volume of 0.17 million observed over the last three months.
The market performance of Revelation Biosciences Inc has been somewhat unstable.
How Financial Performance Impacts Market Capitalization
Revelation Biosciences Inc (REVB) has experienced a quarterly decline of -70.14% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.69M and boasts a workforce of 9 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
How REVB’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for REVB stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
REVB Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. Year to date metric has recorded a loss of -86.04%.However, over the last six months, we can see a stronger performance of -91.47%. Over the last 30 days, the price of REVB has leaped by -63.99%. And in the last five days, it has fallen by -54.63%.
